Portal de Periódicos da CAPES

Screening of the pathogen box for the identification of anti-Acanthamoeba agents

2019; Elsevier BV; Volume: 201; Linguagem: Inglês

10.1016/j.exppara.2019.04.013

1090-2449

Inés Sifaoui, María Reyes‐Batlle, Atteneri López‐Arencibia, Olfa Chiboub, Carlos J. Bethencourt-Estrella, Desirée San Nicolás-Hernández, Rubén L. Rodríguez-Expósito, Aitor Rizo-Liendo, José E. Piñero, Jacob Lorenzo‐Morales,

Bacillus and Francisella bacterial research

Acanthamoeba are free living amoeba that have been isolated from different environments like soil, water, air dust. Moreover, they are also able to act as opportunist pathogens, mainly causing a fatal encephalitis and also keratitis in both human and animals. This study was aimed to evaluate the activity of the Medicines for Malaria Venture (MMV) compounds against the trophozoite stage of Acanthamoeba castellanii Neff. Sixteen compounds showed ≥90% inhibition of parasite growth in the initial screen (10 μM). Those set were further evaluated to determine the inhibitor concentration that inhibit the 50% of the initial population and cytotoxicity against murine macrophages. Among the compounds included in the pathogen box, pentamidine and posaconazole were the most effective against this parasite with an of IC50 of 0.567 ± 0.04 and 0.630 ± 0.11, respectively.